• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CNBC's Final Trades: Integer Holdings, Electric Vehicles, Vistra And This Leisure Stock

    4/21/22 9:12:15 AM ET
    $DOCU
    $DRIV
    $ITGR
    $JNJ
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $DOCU alert in real time by email

    On CNBC’s “Halftime Report Final Trades,” Karen Firestone of Aureus Asset Management said she was “moving away from large cap tech names.” She named Integer Holdings Corp (NYSE:ITGR) as her pick and stated, “We’re starting to see a real resurgence in elective procedures.”

    Johnson & Johnson’s (NYSE:JNJ) earnings release on Wednesday showed that “their medical devices business was up 6%,” Firestone said.

    “Integer plays in that market” and there could be a “huge surge, as the backlogs are filled and move into sales in the second half of this year and 2023 will be very strong,” she added.

    Liz Young of BNY Mellon Investment Management chose Global X Autonomous & Electric Vehicles ETF (NASDAQ:DRIV), saying this is a “good entry point.”

    "They’ve been beaten up this year. High gas prices only intensify this theme. I think this is something that has a lot of growth potential for the next two to five years," said Young.

    Check out EV stocks making big moves in the premarket.

    Pete Najarian said he was “sticking with energy” and named Vistra Corp (NYSE:VST) as his final trade.

    Joseph Terranova of Virtus Investment Partners chose Marriott International Inc (NASDAQ:MAR).

    “It’s trading at an all-time high. It’s great to own it on a day where you’re seeing Roblox (NYSE:RBLX) down 12%, DocuSign (NASDAQ:DOCU) down 6% and laggards are really laggards.”

    Get the next $DOCU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DOCU
    $DRIV
    $ITGR
    $JNJ

    CompanyDatePrice TargetRatingAnalyst
    Roblox Corporation
    $RBLX
    4/22/2026$140.00 → $125.00Buy
    Goldman
    DocuSign Inc.
    $DOCU
    4/10/2026$50.00Buy → Neutral
    Citigroup
    Johnson & Johnson
    $JNJ
    4/8/2026$250.00Buy
    TD Cowen
    Roblox Corporation
    $RBLX
    4/6/2026$97.00 → $78.00Overweight
    Wells Fargo
    DocuSign Inc.
    $DOCU
    3/31/2026$52.00Underperform
    BofA Securities
    Roblox Corporation
    $RBLX
    3/4/2026$65.00Neutral
    DA Davidson
    DocuSign Inc.
    $DOCU
    2/23/2026$45.00Buy → Hold
    Jefferies
    Integer Holdings Corporation
    $ITGR
    2/20/2026$95.00Hold → Buy
    The Benchmark Company
    More analyst ratings

    $DOCU
    $DRIV
    $ITGR
    $JNJ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mastantuono Gina bought $950 worth of shares (22 units at $43.20) and sold $790 worth of shares (22 units at $35.90) (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/13/26 5:07:32 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    EVP, Global Ops and Manufactur Harris John A bought $115,500 worth of shares (1,650 units at $70.00), increasing direct ownership by 37% to 6,066 units (SEC Form 4)

    4 - Integer Holdings Corp (0001114483) (Issuer)

    11/13/25 4:18:50 PM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    EVP, Chief Financial Officer Smith Diron bought $74,967 worth of shares (1,116 units at $67.19), increasing direct ownership by 17% to 7,698 units (SEC Form 4)

    4 - Integer Holdings Corp (0001114483) (Issuer)

    11/10/25 8:19:02 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $DOCU
    $DRIV
    $ITGR
    $JNJ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)

    Through 120 weeks of follow-up, IMAAVY delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including anti-AChR+ and anti-MuSK+Patients achieving sustained minimal symptom expression (MSE) experienced greater improvements in quality of life than those with transient MSE in a post-hoc analysis of the Phase 3 studyEPIC, the first head-to-head study of IMAAVY versus another FcRn blocker in generalized myasthenia gravis, is now enrolling participantsHORSHAM, Pa., April 22, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced new data from the Phase 3 Vivacity-MG3 study and ongoing open label extension (OLE) in a broad population o

    4/22/26 8:05:00 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

    Johnson & Johnson (NYSE:JNJ) will participate in the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19th. Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time. This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com. The audio webcast replay will be available approximately 48 hours after the webcast. View source version on businesswire.com: https://www.businesswire.com/news/home/20260421719308/en/ Media contact: [email protected] Investor contact: [email protected]

    4/21/26 4:22:00 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut of CARTOSOUND SONATA, to Advance Arrhythmia Care at HRS 2026

    As Johnson & Johnson celebrates 30 years of CARTO, the launch of CARTOSOUND SONATA brings new AI-based imaging and mapping capabilitiesi to electrophysiology A total of 17 abstracts will be presented, including new clinical data for the VARIPULSE Platform Johnson & Johnson today announced it will showcase the latest advances across its electrophysiology portfolio at the 2026 Heart Rhythm Society (HRS) Annual Meeting, including new evidence in pulsed field ablation (PFA), and innovations in cardiac mapping and imaging. At HRS 2026, the company will launch the CARTOSOUND SONATA Module, leveraging artificial intelligence with the CARTO System to automatically transform intracardiac echoc

    4/21/26 7:45:00 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOCU
    $DRIV
    $ITGR
    $JNJ
    SEC Filings

    View All

    SEC Form 10-Q filed by Johnson & Johnson

    10-Q - JOHNSON & JOHNSON (0000200406) (Filer)

    4/22/26 4:02:41 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by DocuSign Inc.

    DEF 14A - DOCUSIGN, INC. (0001261333) (Filer)

    4/16/26 4:16:15 PM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEFA14A filed by Roblox Corporation

    DEFA14A - Roblox Corp (0001315098) (Filer)

    4/16/26 4:07:15 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $DOCU
    $DRIV
    $ITGR
    $JNJ
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    July 21, 2023 - FDA Roundup: July 21, 2023

    For Immediate Release: July 21, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA Center for Tobacco Products (CTP) announced that the center will host a virtual listening session on Aug. 22, 2023. During this listening session, CTP is requesting feedback on the development of a new 5-year strategic plan for the center, includin

    7/21/23 4:02:23 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 5, 2022 - Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

    For Immediate Release: May 05, 2022 Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not

    5/5/22 4:51:11 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 18, 2021 - Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots

    For Immediate Release: August 18, 2021 Today, public health and medical experts from the U.S. Department of Health and Human Services (HHS) released the following statement on the Administration’s plan for COVID-19 booster shots for the American people. The statement is attributable to Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC); Dr. Janet Woodcock, Acting Commissione

    8/18/21 1:06:11 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOCU
    $DRIV
    $ITGR
    $JNJ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Rawlings Amy Marie

    4 - Roblox Corp (0001315098) (Issuer)

    4/20/26 7:38:22 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Kaufman Matthew D

    4 - Roblox Corp (0001315098) (Issuer)

    4/15/26 6:36:51 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Reinstra Mark

    4 - Roblox Corp (0001315098) (Issuer)

    4/15/26 6:27:26 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $DOCU
    $DRIV
    $ITGR
    $JNJ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman reiterated coverage on Roblox with a new price target

    Goldman reiterated coverage of Roblox with a rating of Buy and set a new price target of $125.00 from $140.00 previously

    4/22/26 8:06:58 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    DocuSign downgraded by Citigroup with a new price target

    Citigroup downgraded DocuSign from Buy to Neutral and set a new price target of $50.00

    4/10/26 8:29:33 AM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    TD Cowen resumed coverage on Johnson & Johnson with a new price target

    TD Cowen resumed coverage of Johnson & Johnson with a rating of Buy and set a new price target of $250.00

    4/8/26 8:36:42 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOCU
    $DRIV
    $ITGR
    $JNJ
    Leadership Updates

    Live Leadership Updates

    View All

    Integer Announces Board Leadership Transition

    PLANO, Texas, April 06, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced Pamela G. Bailey, who currently serves as Integer's independent Chair of the Board, will not stand for re-election at the Company's 2026 Annual Meeting of Stockholders, scheduled for May 20, 2026. Following the Annual Meeting, the Board intends to appoint current director Donald J. Spence to serve as independent Chair of the Board. "It has been a privilege to serve on the Integer Board and to play my part in the Company's growth and strategic success," said Ms. Bailey. "I am confident that und

    4/6/26 5:00:51 PM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Marriott International and Lefay Announce Milestone Deal to Grow Luxury Wellness Offerings Globally

    Key FactsMarriott International and the Leali family, founders of Lefay, today announced their plans to enter into a joint venture to bring the highly awarded luxury wellness hospitality brand Lefay into the Marriott portfolio.Lefay will be the first brand in Marriott's portfolio dedicated exclusively to luxury wellness.The Lefay portfolio features two award-winning luxury resorts in Lago di Garda and Dolomiti Italy—both located in nature‑rich leisure destinations. Additionally, the brand's pipeline includes three properties under development in Tuscany, Southern Italy, and the Swiss Alps.Together, the parties intend to grow the brand around the world, leveraging Marriott's powerful developm

    3/31/26 1:15:00 AM ET
    $MAR
    Hotels/Resorts
    Consumer Discretionary

    Roblox Expands Board of Directors with the Addition of Dennis Durkin

    Roblox Corporation (NYSE:RBLX), a global immersive gaming and creation platform, today announced the expansion of its Board of Directors with the appointment of Dennis Durkin. Durkin will join as an independent director and serve on the Audit and Compliance Committee and the Leadership Development and Compensation Committee. Durkin has nearly thirty years of experience in the technology and video game sectors, most recently serving as Chief Financial Officer and President of Emerging Businesses at Activision Blizzard. "Our goal is to enable high-fidelity experiences that run seamlessly on any device, anywhere in the world," said David Baszucki, founder and CEO of Roblox. "Dennis has spent

    3/20/26 9:00:00 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $DOCU
    $DRIV
    $ITGR
    $JNJ
    Financials

    Live finance-specific insights

    View All

    Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%

    Johnson & Johnson (NYSE:JNJ) today announced that its Board of Directors has declared a 3.1% increase in the quarterly dividend, from $1.30 per share to $1.34 per share, marking the 64th year of consecutive increases. At the new rate, the indicated dividend on an annual basis is $5.36 per share compared to the previous rate of $5.20 per share. The next quarterly dividend is payable on June 9, 2026 to shareholders of record at the close of business on May 26, 2026. The ex-dividend date is May 26, 2026. About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, tr

    4/14/26 6:21:00 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Johnson & Johnson reports Q1 2026 results, raises 2026 outlook

    2026 First-Quarter reported sales growth of 9.9% to $24.1 Billion with operational growth of 6.4%* and adjusted operational growth of 5.3%* 2026 First-Quarter earnings per share (EPS) of $2.14 and adjusted EPS of $2.70 Company increases 2026 guidance with estimated reported sales of $100.8 Billion or 7.0% at the midpoint, and adjusted EPS4 of $11.55 or 7.1% at the midpoint Solidifying path to double-digit growth by the end of the decade, with significant progress for patients with the approvals of ICOTYDE the first-and-only targeted oral peptide for plaque psoriasis, TECVAYLI plus DARZALEX FASPRO as early as second line for patients with relapsed/refractory multiple myeloma, VARIP

    4/14/26 6:20:00 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Marriott International Announces Release Date For First Quarter 2026 Earnings

    BETHESDA, Md., April 13, 2026 /PRNewswire/ -- Marriott International, Inc. (NASDAQ:MAR) will report first quarter 2026 earnings results on Wednesday, May 6, 2026, at approximately 7:00 a.m. Eastern Time (ET). The company will hold a conference call for the investment community on Wednesday, May 6, 2026, at 8:30 a.m. (ET). Marriott International's President and Chief Executive Officer, Anthony Capuano, and Executive Vice President and Chief Financial Officer, Jennifer Mason, will discuss the company's performance. The conference call will be webcast simultaneously via Marriott's

    4/13/26 8:30:00 AM ET
    $MAR
    Hotels/Resorts
    Consumer Discretionary

    $DOCU
    $DRIV
    $ITGR
    $JNJ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Roblox Corporation

    SC 13G/A - Roblox Corp (0001315098) (Subject)

    11/14/24 5:47:35 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Roblox Corporation

    SC 13G/A - Roblox Corp (0001315098) (Subject)

    11/13/24 4:15:38 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Vistra Corp.

    SC 13G - Vistra Corp. (0001692819) (Subject)

    11/12/24 10:40:28 AM ET
    $VST
    Electric Utilities: Central
    Utilities